PublizoomAward notice Supplies
Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria
Melilla - Place of performance
- Melilla
- Estimated value
- €682,009 excl. VAT
- Amount awarded
- €114,290 excl. VAT
- Bids received
- 1
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 27 August 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Suministro de medicamentos principios activos: Interferon Beta 1-A, Cannabinol-Ronabinol y Avelumab, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.
Awarded to
2 lots
- Medicamento Interferon BETA 1-A
- Medicamento Avelumab
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €350,000
- Median
- €846,164
- A quarter above
- €2,267,877
Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 592426-2026.